Not very silent at all.
Waiting for progress on REE and clarification on PGM's. My reading is the (pgm) grades
and processing times may well lead to a lucrative project. Not in
short term interests of the co to pursue this costly research path for now.
Better employ capital to another (REE) lucrative project for now.
I suspect the bioleaching supply side of microbes will only get better with time as there
is more than one company pursuing it.
Ann: Quarterly Activities Report, page-31
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BCM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.108M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 4679235 | 0.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.9¢ | 549999 | 2 |
View Market Depth
| Last trade - 09.59am 14/11/2024 (20 minute delay) ? |
| BCM (ASX) Chart |
Day chart unavailable